Jo Viney

Dr. Jo Viney brings a distinguished track record in drug discovery and development to the board of directors at Graphite Bio. She currently serves as president, chief scientific officer, and co-founder of Pandion Therapeutics, now a wholly-owned subsidiary of Merck & Co., Inc. Prior to founding Pandion, Dr. Viney served most recently as senior vice president, drug discovery at Biogen. Throughout her career, Dr. Viney has been an advocate for workplace inclusiveness. From 2015 – 2020, she served on the board of WEST, a non-profit organization supporting early to mid-career women, and was WEST’s President for the 2017 – 2018 term. Dr. Viney has maintained longstanding memberships with the Society for Mucosal Immunology (SMI) and the American Association of Immunologists (AAI). She has served numerous terms on the SMI Board and was president from 2011 – 2013. In 2020, Dr. Viney was chosen as one of FiercePharma’s Fiercest Women in Life Sciences. Dr. Viney is also a member of the board of directors for Finch Therapeutics and Harpoon Therapeutics, and she serves on the Scientific Advisory Board for HotSpot Therapeutics.